ASCLETIS-B (01672) spent 2.6099 million Hong Kong dollars to repurchase 200,000 shares on December 16th.
GeLi Pharmaceutical-B (01672) announced that on December 16, 2025, it spent HKD 2.6099 million to repurchase 200,000 shares.
ASCLETIS-B (01672) announced on December 16, 2025 the repurchase of 200,000 shares at a cost of 2.6099 million Hong Kong dollars.
Related Articles
US Stock Market Move | Pfizer Inc. (PFE.US) fell more than 4%, with the company expecting a slowdown in revenue growth in 2026.
US Stock Market Move | Quantum computing concept stock rose, IonQ Inc (IONQ.US) rose more than 4%.
US Stock Market Move | Hesai (HSAI.US) rose more than 2%, the next generation L3 automatic driving laser radar solution will debut at CES 2026.
US Stock Market Move | Pfizer Inc. (PFE.US) fell more than 4%, with the company expecting a slowdown in revenue growth in 2026.
US Stock Market Move | Quantum computing concept stock rose, IonQ Inc (IONQ.US) rose more than 4%.
US Stock Market Move | Hesai (HSAI.US) rose more than 2%, the next generation L3 automatic driving laser radar solution will debut at CES 2026.
RECOMMEND
Super Central Bank Week Arrives! Japan Leads With A Rate Hike As Developed Economies End The Rate‑Cut Cycle, Will The Fed Cut Alone Next Year?
16/12/2025
What Guidance Does The Economic Work Conference Offer For Cross‑Year Market Direction?
16/12/2025
Trade Surplus Tops One Trillion USD: New Challenges For China’s Foreign Trade | Instant Commentary
16/12/2025
